New research from North Carolina State University and the University of Michigan finds that bile acids which are altered by bacteria normally living in the large intestine inhibit the growth of Clostridium difficile, or C. diff. C. diff is a harmful bacterium that can cause painful and sometimes fatal infections. The work sheds light on the ways in which some commonly used antibiotics can promote C. diff infections by killing off the bile acid-altering microbes.
C. diff exists in the environment as a dormant spore. To colonize the gut, C. diff. spores need to germinate and become growing bacteria that produce toxins and damage the large intestine. Researchers know that the use of certain antibiotics lead to a higher risk of C. diff infections, particularly among hospital patients. Casey Theriot, an assistant professor of infectious disease at NC State, wanted to know exactly how C. diff spores were interacting with the microbiota, or natural bacterial environment, within the gut.
“We know that within a healthy gut environment, the growth of C. diff is inhibited,” Theriot says. “But we wanted to learn more about the mechanisms behind that inhibitory effect.”
Bile acids are made from cholesterol and aid in the digestion and absorption of fats. They also control lipoprotein, glucose, drug and energy metabolism. Primary bile acids are made in the liver and travel through the intestinal tract. In the large intestine, bacteria convert these to secondary bile acids, of which Theriot found many have an inhibitory effect on C. diff growth.
Theriot started the project while a research investigator at the University of Michigan with infectious diseases physician Vincent Young and undergraduate researcher Alison Bowman. The researchers looked at the intestinal contents of mice before and after treatment with many different antibiotics. They identified 26 different primary and secondary bile acids and defined the concentrations of those acids before and after treatment. Then they added C. diff spores to the contents in order to find out how the bacterium may germinate and grow in an actual gut environment.
Interestingly, they found that the primary bile acids in the small intestine allowed spores to germinate, or begin to grow, regardless of the antibiotic treatment.
But when the spores reached the large intestine, where normal gut bacteria generate secondary bile acids, the researchers found that those secondary bile acids stopped the C. diff from growing. When those bacteria – and the secondary bile acids – were not present following antibiotic treatment, the C. diff was able to quickly grow.
“These findings are a first step in understanding how the gut microbiota regulates bile acids throughout the intestine,” says Theriot. “Hopefully they will aid the development of future therapies for C. difficile infection and other metabolically relevant disorders such as obesity and diabetes.”
The researchers’ findings appear in mSphere. The research was funded by the National Institutes of Health (grant K01GM109236).